Report Categories
View AllRecent Articles
View All
The RD spending story behind GigaMedia Limited GIGM innovation GigaMedia Limited posts 009 per share loss no consensus estimates
Why CEA Warrant BNCWW might be the steady performer you need Surges 20260505
MATH Metalpha flags longterm blockchain service growth opportunities in its latest quarterly earnings call
What Applied Mat AMAT does that builds long term value Q1 2026 Profit Exceeds Views
Eli Lilly Targets Infectious Disease with Nearly 4 Billion Vaccine Deals
Robert Kiyosaki Predicts Gold at 10000 and Silver 200 Warns of Imminent Stock Market Crash
AIDriven Drug Discovery Could Accelerate Treatments for Brain Conditions Like MND
Wall Street Analysts Offer Mixed Outlook on Avery Dennisons Stock Trajectory
Retail Hiring Surge Masks Underlying Consumer Caution April Jobs Data Shows
SpaceX Delays Starship Launch Amid Potential RecordBreaking IPO Plans
KGS Q1 2026 Earnings EPS Surges Past Estimates as Operational Efficiency Improves
HTT Q1 2023 Earnings Solid EPS Performance Drives Stock Rally
CISO Q2 2025 Earnings EPS of 009 as Shares Decline
OZK Q1 2026 Earnings Marginal EPS Miss Amid Solid Underlying Performance
Pioneer Power Solutions Inc PPSI Q1 2026 Earnings Loss Widens Stock Rises Unexpectedly
AdaptHealth Corp AHCO Q1 2026 Earnings EPS Misses Estimates by a Wide Margin
Watsco Inc WSO Extends Gains Approaching Key Resistance Zone
H2O America HTO Edges Lower as Consolidation Continues
Tyra Biosciences TYRA Slips 148 as Stock Approaches Key Support at 3105
Nelnet Inc NNI Gains 12 as Stock Holds Above Key Support Level
Cracker Barrel CBRL Rallies 378 as Shares Test Key Resistance at 3630
GWAV Greenwave shares rise despite Q3 loss and revenue decline investors eye turnaround prospects
How Dingdong DDL margins compare to industry leaders 078 20260506
What AXT AXTI does that makes it resilient Slight Loss 20260506
Fidelity MSCI Consumer Discretionary Index ETF FDIS Positioning for Resilience Amid Mixed Inflation and Geopolitical Headwinds
Is Cue Biopharma CUE stock under pressure Q3 2025 Profit Exceeds Views
KYMR Kymera Therapeutics posts wider than expected Q4 2025 loss sending shares down 259 percent today